Search Within

Shari Goldfarb

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (89)
  2. Journal Article (52)
  3. Book Section (4)
  4. Review (2)
  5. Correspondence (1)
  6. Miscellaneous (1)
Groups
  1. Breast Medicine Service (149)
  2. Department of Medicine (149)
  3. Epidemiology and Biostatistics (149)
  4. Health Outcomes Research Group (149)
  5. Population Sciences Research Program (149)
  6. Solid Tumor Oncology Division (149)

More Groups

People
  1. Maura Dickler (50)
  2. Jeanne Carter (37)
  3. Mario Lacouture (34)
  4. Sujata Patil (34)
  5. Clifford Hudis (31)
  6. Diana Lake (22)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (8)
  4. 2022 (11)
  5. 2021 (9)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Cancer Research (25)
  3. Journal of Sexual Medicine (12)
  4. Breast Cancer Research and Treatment (9)
  5. Annals of Surgical Oncology (8)
  6. Fertility and Sterility (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (37)
  2. American Association for Cancer Research (25)
  3. Elsevier Inc. (23)
  4. Springer (21)
  5. Elsevier Science, Inc. (7)
  6. Lippincott Williams & Wilkins (6)

More Publishers

Results (149)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First in-human, phase I study of the safety, tolerability and pharmacokinetics (PK) of BPM31543 (topical calcitriol solution) in adult cancer patients: Preliminary results
    Meeting Abstract

    Goldfarb, S. B.; Stevens, J.; Brouwer, S.; Benaim, E.; Narain, N. R.; Sarangarajan, R.; Kracunas, A.; Jimenez, J. J.; Belum, V. R.; Ciccolini, K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A prospective longitudinal study of the impact of breast cancer treatment with adjuvant chemotherapy or tamoxifen alone on ovarian reserve
    Meeting Abstract

    Goldfarb, S. B.; Bedoschi, G.; Grunblatt, E.; Goswami, S.; Cigler, T.; Quistorff, J.; Pacheco, F.; Stobezki, R.; Robson, M.; Moy, F.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program
    Journal Article

    Carter, J.; Stabile, C.; Seidel, B.; Baser, R. E.; Gunn, A. R.; Chi, S.; Steed, R. F.; Goldfarb, S.; Goldfrank, D. J.
    Supportive Care in Cancer (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of daily PI3K alpha inhibitor BYL719 plus letrozole (L) or exemestane (E) for patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Modi, S.; Datko, F. M.; Moynahan, M. E.; Zamora, S.; D'Andrea, G.; Lake, D.; Goldfarb, S. B.; Patil, S.; Singh, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Monitoring PIK3CA mutant allele fraction (AF) in cell-free DNA (cfDNA) in metastatic breast cancer (MBC) patients treated with PI3K alpha-inhibitor plus letrozole (L) or exemestane (E)
    Meeting Abstract

    Moynahan, M. E.; Sung, P.; Asham, M.; Zamora, S.; Shah, P. D.; Modi, S.; Lake, D.; D'Andrea, G.; Goldfarb, S. B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Sexual dysfunction in women with lymphoma: Prevalence and etiologies
    Meeting Abstract

    Goldfarb, S. B.; Jackson, T.; Carter, J.; Dickler, M. N.; Noy, A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A Prospective Longitudinal Study of the Impact of Breast Cancer Chemotherapy on Ovarian Reserve: Do Individuals Have Differing Susceptibilities?
    Meeting Abstract

    Oktay, K.; Goldfarb, S.; Bedoschi, G.; Quistorff, J.; Grunblatt, E.; Cigler, T.; Moy, F.; Patil, S.; Goswami, S.; Dickler, M.
    Fertility and Sterility (2014)

    Fulltext@MSK | Save